Fluorecare POCT – Comprehensive Point-of-Care Testing with Advanced FIA Technology
Fluorecare POCT represents a new generation of diagnostic innovation, combining accuracy, speed, and convenience to meet the growing demand for reliable point-of-care testing. Built on Fluorescence Immunoassay (FIA) technology, it delivers laboratory-quality results within minutes, making it an essential tool for clinicians, laboratories, and hospitals seeking to improve diagnostic efficiency and patient care outcomes.
Unlike conventional testing methods, which often require complex workflows and long turnaround times, Fluorecare POCT simplifies the diagnostic process without compromising on quality. With a wide menu of critical tests, it supports a diverse range of clinical applications including emergency medicine, infectious disease management, inflammation monitoring, and COVID-19 diagnostics.
Wide Range of Tests for Critical Care and Infection Management
Fluorecare POCT offers a comprehensive test portfolio that includes essential biomarkers and infectious disease markers. Each test is designed to provide fast and accurate results that support critical clinical decision-making.
-
D-Dimer – A key marker used in the evaluation of thromboembolic conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). Rapid D-Dimer results are crucial in emergency and intensive care settings.
-
Ferritin – Helps in assessing iron storage and plays an important role in diagnosing anemia, inflammatory diseases, and monitoring cytokine storm severity in severe infections.
-
C-Reactive Protein (CRP) – An important biomarker for detecting inflammation, infection, and sepsis. CRP testing supports early diagnosis and helps monitor treatment effectiveness.
-
Interleukin-6 (IL-6) – A sensitive marker of inflammation and cytokine release syndrome, widely used in monitoring immune responses and severe infections.
-
Procalcitonin (PCT) – A powerful biomarker for bacterial infection and sepsis, enabling clinicians to differentiate between bacterial and viral infections and guide antibiotic therapy.
-
Serum Amyloid A (SAA) – A sensitive acute-phase protein useful in detecting early infection and inflammatory responses.
Specialized SARS-CoV-2 Testing Solutions
In addition to general biomarkers, Fluorecare POCT provides a dedicated range of COVID-19 diagnostic tests, ensuring rapid and reliable detection at the point of care.
-
SARS-CoV-2 Spike Protein Test – Detects viral antigens for rapid and direct confirmation of infection.
-
SARS-CoV-2 Neutralizing Antibody Test – Evaluates immune protection by detecting functional antibodies that block viral entry into host cells.
-
SARS-CoV-2 IgM & IgG Combined Antibody Test – Identifies both early-phase (IgM) and long-term (IgG) immune responses, providing a comprehensive picture of infection and immunity status.
These tests play a vital role in patient screening, disease monitoring, post-vaccination evaluation, and public health management during and beyond the pandemic.
Advantages of Fluorecare POCT
Fluorecare POCT is more than just a testing device; it is a complete diagnostic ecosystem designed to enhance clinical workflows and patient care. Key benefits include:
-
Speed and Efficiency – Delivers results in minutes, allowing faster clinical decisions in critical situations.
-
High Sensitivity and Specificity – Fluorescence Immunoassay technology ensures reliable results comparable to laboratory standards.
-
Ease of Use – Simple operation with minimal training required, making it ideal for hospitals, clinics, and decentralized testing centers.
-
Compact and Portable Design – Optimized for bedside testing, emergency rooms, outpatient clinics, and mobile healthcare units.
-
Broad Clinical Applications – Suitable for emergency care, infectious disease monitoring, chronic disease management, and outbreak control.
Applications Across Healthcare Settings
Fluorecare POCT has been designed to support a wide variety of clinical applications:
-
Hospitals & Intensive Care Units (ICUs) – Rapid biomarker testing for critical conditions such as sepsis, cytokine storms, and coagulation disorders.
-
Diagnostic Laboratories – Extends testing capacity with quick turnaround times and high throughput.
-
Clinics & Emergency Rooms – Provides immediate results, enabling same-visit consultations and treatment plans.
-
Public Health Programs – Supports large-scale infectious disease screening and outbreak control.
-
Post-Vaccination Monitoring – Evaluates immune response through neutralizing antibody detection.
Conclusion
Fluorecare POCT redefines the standard for point-of-care diagnostics with its wide test menu, advanced FIA technology, and rapid results delivery. Whether it is identifying life-threatening conditions such as sepsis and thrombosis, monitoring inflammatory markers, or detecting SARS-CoV-2 infection and immunity, Fluorecare POCT provides clinicians with the insights they need—when they need them most.
By combining accuracy, speed, and versatility, Fluorecare POCT empowers healthcare providers to make timely, confident decisions that improve patient outcomes and strengthen the overall efficiency of clinical workflows. It is truly a comprehensive solution for modern diagnostic challenges.